FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias

Two months after Democratic lawmakers expressed concern about potential racial disparities in pulse oximeter readings — calling the issue a matter of “life or death” — the Food and Drug Administration on Friday issued a public warning about the devices, acknowledging they had “limitations.”